About Spravato® / Ketamine
What is Spravato?
Ketamine therapy has been a major advancement in treating depression. Spravato is a nasal spray formulation of Ketamine. It works in a very different way from traditional antidepressants, and is often effective even for people who have had poor results from previous medication. Another significant advantage is that patients often see results much more quickly than from traditional antidepressants.
It can be effective for:
- Treatment-resistant depression (TRD)
- Depressive symptoms with major depressive disorder (MDD) with suicidal thoughts or actions
Learn more about Spravato from the manufacturer (offsite)
At-a-glance Facts
- Studied in adults with treatment-resistant depression
- Taken with an oral antidepressant
- After 16 weeks of therapy, those patients who stayed on SPRAVATO did better than those who stopped therapy
- Taken as a self-administered nasal spray under the supervision of a healthcare provider
- Greater reduction of depressive symptoms at four weeks (compared to those who received a placebo and oral antidepressant)
- Notify your healthcare provider if you have a history of drug or alcohol abuse
Our team can help you evaluate whether Spravato might be a viable treatment option for you.
Spravato is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if Spravato is safe or effective as an anesthetic medicine.
It is not known if Spravato is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. Spravato is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of Spravato.
It is not known if SPRAVATO® is safe and effective in children.